Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study

NCT01944371 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators